19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Treatment of conditions associated with hyperinsulinaemia

Tensha Therapeutics
Indazole compounds and uses thereof

Incyte
Apoptosis signal-regulating kinase inhibitors

Gilead Sciences
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

Arena Pharmaceuticals
Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Incyte
Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds

Suzhou Zelgen Biopharmaceuticals
Acetyl-CoA carboxylase modulators

Monsanto Technology
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Galapagos
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease as a Clinical Candidate for the Potential Treatment of COVID-19.

Pfizer
Purinones as ubiquitin-specific protease 1 inhibitors

Forma Therapeutics
Substituted B-amino acid derivatives as CXCR3 receptor antagonists

Sanofi
Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds

Bristol-Myers Squibb
Pyridine derivatives

Hoffmann-La Roche
Substituted 4-aminocyclohexane derivatives

Gruenenthal
Triazolo compounds as PDE10 inhibitors

Hoffmann-La Roche
Compound for increasing kinase active and application thereof

Fujian Haixi Pharmaceuticals
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity.

Hanoi University of Pharmacy
Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives.

Chulabhorn Research Institute
Structure and Inhibition of Microbiome ß-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

University of North Carolina at Chapel Hill